Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 Diabetes
Clinical trial NCT05160272 · COMPLETED
Trial details
- NCT number
- NCT05160272
- Sponsor
- The Deutsche Diabetes Forschungsgesellschaft e.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-07
- Primary completion
- 2024-12-17
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.